source
- FDA signals new window for companies with recent complete response letters after commissioner’s exitAfter FDA Commissioner Marty Makary left, the agency indicated it will reconsider drugs that received complete response letters in the past year. The move offers sponsors a chance to resubmit thei…
- FDA issues warning letters to 25 telehealth firms over misleading compounded GLP-1 marketingThe U.S. Food and Drug Administration has sent warning letters to 25 telehealth companies. The letters cite concerns about how the firms promote compounded GLP-1 drugs used for weight loss. The ag…